neuroinflammation will allow faster and more successful treatments. It is especially relevant for multiple sclerosis (MS) patients in whom diseases return periodically. We have used a novel model of spontaneous…
Alzheimer's disease (AD), and multiple electron transport chain (ETC) enzymes in Huntington's disease (HD). Mitochondrial dysfunction occurs in amyotrophic lateral sclerosis and progressive supranuclear palsy. Leber's…
Multiple sclerosis (MS) is a neuroinflammatory disease of the central nervous system (CNS) without effective treatment or medication so far. Current medication cannot fundamentally alter the progressive disease course
effective against a wide range of ailments, from arthritis and chronic pain to multiple sclerosis and cancer, although few scientific studies have proved their benefits. Medical importance of honeybee products
proteins. These formulations have potential application in the treatment of inflammatory conditions such as multiple sclerosis, Crohn?s disease, Parkinson?s disease, and rheumatoid arthritis.. These types of formulations
that FTY720 (Flingolimod), a sphingosine analogue and an FDA approved drug for treatment of multiple sclerosis, showed great antitumorigenic activity against Kasumi-1 cell line, xenograft mouse model and leukemic
mediators of inflammatory responses to generate the events. Most of autoimmune disorders including multiple sclerosis (MS) are preceded by a symptom-free subclinical stage in which the patients
Natalizumab is an effective immunosuppressive therapy for multiple sclerosis that received its initial FDA approval in 2004. Its most notable toxicity is progressive multifocal leukoencephalopathy (PML); an…
rare. Treatment with helminthes and their ova, improved clinical findings of inflammatory bowel disease, multiple-sclerosis, rheumatoid-arthritis and type-I-diabetes-mellitus, in animal models and in human
Multiple sclerosis (MS) is a disease that is both a focal inflammatory and a chronic neurodegenerative disease. The focal inflammatory component is characterized by destruction of central nervous system myelin
human brain while it is induced in the patients affected by Alzheimer Disease (AD), Multiple Sclerosis (MS) and Temporal Lobe Epilepsy (TLE). The expression of immunoproteasome in the brain
mediators of inflammatory responses to generate the events. Most of autoimmune disorders including multiple sclerosis (MS), autoimmune myocarditis (AIM) and autoimmune thyroiditis (AIT) are preceded by a symptom-free…
similar; however they differ in pharmacokinetic parameters. Conditions such as trigeminal neuralgia, neuropathic pain, multiple sclerosis, cerebral palsy, fibromyalgia and diabetic neuropathy are addressed differently…
Gambuzza M E et al. (2016) A new era for immunotherapeutic approaches in multiple sclerosis treatment. J. Clinic. Trials. 6(1):1-3. 3. Gambuzza ... TLR3 agonist as promising candidate in multiple sclerosis management…
discuss the suitability of pandemic vaccines (with or without adjuvant) in patients with multiple sclerosis and other neurological diseases with immunological etiologies. Vaccine adjuvants are used to improve the…
presence of anti-myelin antibodies in patients with early multiple sclerosis (MS) and in MS animal models led to renewed interest in a role for B cells, plasma cells
Multiple Sclerosis (MS) is still a mysterious pathology. A lot of investigation is on course, but it Is hard to get to a solid conclusion/ consensus about how people
surrounding the brain and spinal cord); epilepsy (chronic or acute seizures caused by inflammation); multiple sclerosis (MS - a disease of the immune system or/and the breaking down
surrounding the brain and spinal cord), epilepsy (chronic or acute seizures caused by inflammation), multiple sclerosis (MS-a disease of the immune system or/and the breaking down
skull fontanelles and sutures leading to increased ICT and papilledema and multiple hamartomas in Tuberous sclerosis (3) in infants, to be differentiated from retinoblastoma. Diagnosis of these conditions helped
with functionality) are of great value to monitor demyelination to illustrate the evolution of multiple sclerosis (MS). Anti-MBP autoAbs from MS patients and mice with EAE exhibited specific proteolytic